Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2023 Jul 7;14:1231544. doi: 10.3389/fphar.2023.1231544

Corrigendum: Metabonomic analysis of the anti-hepatic fibrosis effect of Ganlong capsules

ChangLing Lv 1,2, YinRui Li 3, Ling Ou 1,2, Jie Zhou 1,2, Fang Peng 1,2, DingYu Wu 1,2,*
PMCID: PMC10361689  PMID: 37484023

In the published article, there was an error in Figures 3, 6, 9 as published. The reason for this is a mistake was made in the order of BPC pictures of different tissue samples. The corrected Figures 3, 6 and 9 and their captions appear below.

FIGURE 3.

FIGURE 3

Representative BPC of rat liver tissue in positive and negative ion mode for each group.

FIGURE 6.

FIGURE 6

Representative BPC of rat Serum in positive and negative ion mode for each group.

FIGURE 9.

FIGURE 9

Representative BPC graph of rat urine in positive and negative ion mode for each group.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES